Ep. 182 "The Ins and Outs of JAK Inhibitors for Psoriatic Disease"
Psoriasis Uncovered
00:00
Jack Inhibitors and Other Treatments for Psoriatic Disease
Tophositinib was the first Jack inhibitor for autoimmune diseases. It's also approved for psoriatic arthritis, colosing spondylitis, ulcerative colitis and polyarticulageuvinal arthritis. A third Jack inhibitor called barycychnib is approved for rheumatoid arthritis, alopecia arriata,. And interestingly for people who are very sick with COVID-19 and are hospitalized.
Play episode from 06:16
Transcript
